CNS Radiotherapy As Bridging Prior to CAR T-Cell Therapy for Non-Hodgkin B-Cell Lymphoma

被引：0

作者：

Cederquist, Gustav ^{[1
]}

Schefflein, Javin ^{[2
]}

Devlin, Sean M. ^{[3
]}

Hubbeling, Harper ^{[1
]}

Tringale, Kathryn ^{[1
]}

Shah, Gunjan L. ^{[4
]}

Tomas, Ana Alarcon ^{[4
]}

Shouval, Roni ^{[5
]}

Hajj, Carla ^{[1
]}

Fregonese, Beatrice ^{[1
]}

Dahi, Parastoo B. ^{[5
]}

Lin, Richard J. ^{[5
]}

Palomba, Maria Lia ^{[6
]}

Perales, Miguel-Angel ^{[5
]}

Salles, Gilles ^{[6
]}

Falchi, Lorenzo ^{[6
]}

Grommes, Christian ^{[7
]}

Scordo, Michael ^{[5
]}

Yahalom, Joachim ^{[1
]}

Imber, Brandon S. ^{[1
]}

机构：

[1] Mem Sloan Kettering Canc Ctr, Dept Radiat Oncol, 1275 York Ave, New York, NY 10021 USA

[2] Mem Sloan Kettering Canc Ctr, Dept Radiol, 1275 York Ave, New York, NY 10021 USA

[3] Mem Sloan Kettering Canc Ctr, Dept Biostat & Epidemiol, 1275 York Ave, New York, NY 10021 USA

[4] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA

[5] Mem Sloan Kettering Canc Ctr, Dept Med, Adult Bone Marrow Transplant Serv, 1275 York Ave, New York, NY 10021 USA

[6] Mem Sloan Kettering Canc Ctr, Dept Med, Lymphoma Serv, 1275 York Ave, New York, NY 10021 USA

[7] Mem Sloan Kettering Canc, Dept Neurol, New York, NY USA

来源：

BLOOD | 2023年 / 142卷

关键词：

D O I：

10.1182/blood-2023-190326

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页数：4

共 50 条

[41] The promise of CAR T-cell therapy in aggressive B-cell lymphoma
Nair, Ranjit
Neelapu, Sattva S.
BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2018, 31 (03) : 293 - 298
[42] CAR T-cell therapy in diffuse large B-cell lymphoma
Georg Hopfinger
Nina Worel
memo - Magazine of European Medical Oncology, 2020, 13 : 32 - 35
[43] CAR T-cell therapy in diffuse large B-cell lymphoma
Hopfinger, Georg
Worel, Nina
MEMO-MAGAZINE OF EUROPEAN MEDICAL ONCOLOGY, 2020, 13 (01) : 32 - 35
[44] CAR T-cell therapy in refractory large B-cell lymphoma
Stirrups, Robert
LANCET ONCOLOGY, 2018, 19 (01): : E19 - E19
[45] LAG-3 T-cell subsets in the tumor microenvironment of classical Hodgkin lymphoma and B-cell non-Hodgkin lymphoma
Takata, Katsuyoshi
CANCER SCIENCE, 2022, 113 : 1708 - 1708
[46] Impact of Extranodal Involvement on Outcomes with Chimeric Antigen Receptor T-Cell Therapy in B-Cell Non-Hodgkin Lymphoma
Kumar, Vinod
Alotaibi, Shaykhah
Li, Zhuo
Ayala, Ernesto
Kharfan-Dabaja, Mohamed A.
Iqbal, Madiha
BLOOD, 2024, 144 : 5129 - 5130
[47] Efficacy and safety of CAR19/22 T-cell "cocktail" therapy in patients with refractory/relapsed B-cell non-Hodgkin lymphoma.
Huang, Liang
Wang, Na
Li, Chunrui
Xiao, Yi
Cao, Yang
Xiao, Min
Zhang, Yicheng
Zhang, Tongcun
Zhou, Jianfeng
JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
[48] A Rare Case of Malignant T-Cell Non-Hodgkin Lymphoma in a HTLV 1 Carrier With History of Diffuse Large B-Cell Non-Hodgkin Lymphoma
Vafaiezadeh, Farahnaz
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2010, 10 (03): : E42 - E42
[49] CAR T-Cell Therapy for Relapsed/Refractory Non-Hodgkin's Lymphoma: A Comprehensive Review
St-Pierre, Frederique
Gordon, Leo, I
CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2022, 20 (05) : 309 - 318
[50] Dual-targeting CAR T cells for B-cell acute lymphoblastic leukemia and B-cell non-Hodgkin lymphoma
Canedo, Gustavo de Oliveira
Roddie, Claire
Amrolia, Persis J.
BLOOD ADVANCES, 2025, 9 (04) : 704 - 721

← 1 2 3 4 5 →